Stocks and Investing Stocks and Investing
Wed, March 2, 2022
[ 12:00 AM ] - WOPRAI
Daniel Imbro Upgraded (ACVA) to Buy and Increased Target to $19 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
David Lebowitz Maintained (ARQT) at Buy with Increased Target to $37 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Justin Jenkins Maintained (ARIS) at Buy with Increased Target to $18 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Adam Tindle Maintained (ARLO) at Buy with Increased Target to $14 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Jeffrey Rand Maintained (ARLO) at Strong Buy with Increased Target to $14 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Hamed Khorsand Maintained (ARLO) at Strong Buy with Increased Target to $15 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Chris Howerton Upgraded (ARDX) to Strong Buy and Increased Target to $5 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Whit Mayo Maintained (AHCO) at Buy with Decreased Target to $24 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Mark Murphy Upgraded (AI) to Hold and Held Target at $27 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Michael King Maintained (AGEN) at Strong Buy with Increased Target to $280 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Erinn Murphy Maintained (AKA) at Buy with Decreased Target to $180 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Michael Binetti Maintained (AKA) at Hold with Decreased Target to $108 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Paul Fremont Maintained (ALE) at Hold with Decreased Target to $60 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Robert Moskow Maintained (BGS) at Sell with Decreased Target to $26 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Ella Ji Maintained (BIDU) at Strong Buy with Increased Target to $228 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Stephen Bersey Upgraded (ZS) to Strong Buy and Held Target at $296 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Alex Zukin Downgraded (ZM) to Hold and Decreased Target to $100 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Jason Wittes Downgraded (ZBH) to Hold and Held Target at $130 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Jonathan Chang Maintained (ZLAB) at Buy with Decreased Target to $102 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Aaron Kessler Maintained (ZIP) at Strong Buy with Decreased Target to $41 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Ivan Feinseth Maintained (ABNB) at Strong Buy with Increased Target to $214 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Travis Steed Initiated (ABT) at Strong Buy and Held Target at $140 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Nick Giovacchini Maintained (ACHC) at Buy with Increased Target to $78 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Mohit Bansal Maintained (BMY) at Hold with Increased Target to $65 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Mark Mahaney Upgraded (BKNG) to Buy on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Ricardo Alonso Garcia Upgraded (BSAC) to Buy and Increased Target to $24 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Jason Celino Maintained (BSY) at Buy with Decreased Target to $50 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Matthew Hedberg Maintained (BSY) at Buy with Decreased Target to $55 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Christine Cho Downgraded (AM) to Sell and Decreased Target to $10 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Eric Joseph Maintained (AVIR) at Hold with Decreased Target to $8 on, Mar 2nd, 2022

Eric Joseph Maintained (AVIR) at Hold with Decreased Target to $8 on, Mar 2nd, 2022


Published on 2024-10-27 19:54:22 - WOPRAI, Eric Joseph
  Print publication without navigation


Eric Joseph of JP Morgan, Maintained "Atea Pharmaceuticals, Inc." (AVIR) at Hold with Decreased Target from $10 to $8 on, Mar 2nd, 2022.

Eric has made no other calls on AVIR in the last 4 months.



There are 2 other peers that have a rating on AVIR. Out of the 2 peers that are also analyzing AVIR, 1 agrees with Eric's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Roanna Ruiz of "SVB Leerink" Maintained at Hold with Decreased Target to $9 on, Tuesday, March 1st, 2022


This is the rating of the analyst that currently disagrees with Eric

  • Matthew Harrison of "Morgan Stanley" Downgraded from Hold to Sell and Decreased Target to $7 on, Thursday, January 6th, 2022
Contributing Sources